Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a placebo-controlled trial of EPI-743 in children with Rett syndrome
2012-005021-76Phase 2Completed
- Sponsor
- Bioelectron
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Rett syndrome (RTT) comparing EPI-743 with Placebo (2 arms). Primary endpoint: Change in Rett Syndrome clinical Severity Scale. Started Dec 2012; status: completed.
02
Drugs
vatiquinone
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on 2012-005021-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005021-76.